157 related articles for article (PubMed ID: 1684291)
1. Diagnostic utility of oncogenes and their products in human cancer.
McKenzie SJ
Biochim Biophys Acta; 1991 Dec; 1072(2-3):193-214. PubMed ID: 1684291
[TBL] [Abstract][Full Text] [Related]
2. Cellular oncogenes and suppressor genes as prognostic markers in cancer.
Duffy MJ
Clin Biochem; 1993 Dec; 26(6):439-47. PubMed ID: 8124858
[TBL] [Abstract][Full Text] [Related]
3. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
[TBL] [Abstract][Full Text] [Related]
4. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and antioncogenes in human breast carcinoma.
Leslie KO; Howard P
Pathol Annu; 1992; 27 Pt 1():321-42. PubMed ID: 1346552
[No Abstract] [Full Text] [Related]
6. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
7. Role of proto-oncogene activation in carcinogenesis.
Anderson MW; Reynolds SH; You M; Maronpot RM
Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
[TBL] [Abstract][Full Text] [Related]
8. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
[TBL] [Abstract][Full Text] [Related]
9. [Alterations of oncogenes in human cancers].
Tsuda H; Hirohashi S
Gan To Kagaku Ryoho; 1993 May; 20(7):977-83. PubMed ID: 8098201
[TBL] [Abstract][Full Text] [Related]
10. [Oncogenes and anti-oncogenes in breast cancer].
Birnbaum D; Gaudray P
Bull Cancer; 1989; 76(7):677-87. PubMed ID: 2573395
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and leukemia.
Butturini A; Gale RP
Leukemia; 1990 Feb; 4(2):138-60. PubMed ID: 2406517
[TBL] [Abstract][Full Text] [Related]
12. Oncogenes and oncoproteins in occupational carcinogenesis.
Brandt-Rauf PW
Scand J Work Environ Health; 1992; 18 Suppl 1():27-30. PubMed ID: 1357742
[TBL] [Abstract][Full Text] [Related]
13. The involvement of oncogenes and suppressor genes in human neoplasia.
Brodeur GM
Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
[TBL] [Abstract][Full Text] [Related]
14. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
15. [Oncogenes and oncogene products--possibilities and significance of their detection].
Höfler H
Verh Dtsch Ges Pathol; 1990; 74():319-27. PubMed ID: 1708608
[TBL] [Abstract][Full Text] [Related]
16. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
17. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
[TBL] [Abstract][Full Text] [Related]
18. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
[TBL] [Abstract][Full Text] [Related]
19. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
20. [Anticancer agents targeting oncogene products].
Uehara Y
Gan To Kagaku Ryoho; 1993 Sep; 20(12):1885-91. PubMed ID: 8379683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]